ArticleScience advances2022

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity.

Sushrut Kamerkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.